Teradyne (TER) valuation
Teradyne P/E ratio history
Teradyne trades at 31.5 times its earnings over the last twelve months and 24.4 times the earnings analysts expect over the next twelve. At its last 9 fiscal year ends its P/E ranged from 13.2 (year to Dec 2018) to 55.8 (year to Dec 2025), with a median of 29.6.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Dec 31, 2025 | $193.56 | $3.47 | 55.8 | 41.1 |
| Dec 31, 2024 | $125.92 | $3.32 | 37.9 | 31.8 |
| Dec 31, 2023 | $108.52 | $2.73 | 39.8 | 31.1 |
| Dec 31, 2022 | $87.35 | $4.22 | 20.7 | — |
| Dec 31, 2021 | $163.53 | $5.53 | 29.6 | 26.2 |
| Dec 31, 2020 | $119.89 | $4.28 | 28.0 | — |
| Dec 31, 2019 | $68.19 | $2.60 | 26.2 | — |
| Dec 31, 2018 | $31.38 | $2.37 | 13.2 | — |
| Dec 31, 2017 | $41.87 | $1.27 | 33.0 | — |
| Dec 31, 2016 | $25.40 | -$0.22 | n/m | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Teradyne valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| TeradyneTER | $43.0B | 31.5 | 24.4 | 9.6 |
| Microchip TechnologyMCHP | $41.9B | 113.7 | 19.9 | 8.2 |
| Astera LabsALAB | $44.3B | 128.1 | 49.6 | 36.9 |
| Monolithic Power SystemsMPWR | $59.5B | 74.0 | 30.8 | 18.2 |
| NXP SemiconductorsNXPI | $65.5B | 20.4 | 14.8 | 4.7 |
| Credo TechnologyCRDO | $28.2B | 53.2 | 21.0 | 17.7 |
| ON SemiconductorON | $28.1B | 47.5 | 18.4 | 4.5 |
| Qnity ElectronicsQ | $24.4B | 41.8 | 23.1 | 4.7 |
| SynopsysSNPS | $89.5B | 81.9 | 26.4 | 9.5 |
| Peer median | 63.6 | 22.1 | 8.8 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: TER financials · TER returns
No forecast, no recommendation. This page describes Teradyne from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.